In short-interval group, 50.5% of patients experienced at least one adverse events, with the most common adverse events being anemia (39.6%), thyroid dysfunction (13.2%), increased alanine transaminase (11.0%), leukopenia (8.8%) and neutropenia (8.8%). Here, GPT is linked to anemia (phenotype).